PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33240985 ↗2020Reported benefit

Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway.

RatIschaemia-reperfusionCerebral (MCAO/stroke)Sprague DawleyMalen = 8 rats per group across 7 groups (56 rats surviving to 24 h)Intraperitoneal injection300,000 U/kg15 min after MCAO

Model: Cerebral ischaemia-reperfusion induced by intraluminal middle cerebral artery occlusion (MCAO) with a 0.3 mm nylon thread inserted 18.0 plus or minus 2.0 mm, 2 h of ischaemia followed by 24 h of reperfusion, under sodium pentobarbital anaesthesia (30 mg/kg intraperitoneally)

Ulinastatin ameliorated MCAO-induced histological damage, reduced TUNEL-positive apoptotic cells and infarct volume, and lowered caspase-3 and ICAM-1 expression (P<0.01). It raised SOD activity and GSH content and lowered MDA and ROS, and reduced serum IL-6, IL-1beta and IL-18 (P<0.01). Nrf-2 and H…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.